{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:12:22Z","timestamp":1779243142697,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:00:00Z","timestamp":1715299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00520-024-08543-x","type":"journal-article","created":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:01:51Z","timestamp":1715317311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MASCC 2023 Patient-Centered Antiemetic Guidelines and Education Statements: an evidence-based and consensus resource for patients"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4004-7834","authenticated-orcid":false,"given":"Mary Lou","family":"Affronti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Molassiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Tinianov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Clark-Snow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Scotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,10]]},"reference":[{"issue":"14","key":"8543_CR1","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJMra1515442","volume":"374","author":"RM Navari","year":"2016","unstructured":"Navari RM, Aapro M (2016) Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med 374(14):1356\u20131367. https:\/\/doi.org\/10.1056\/NEJMra1515442","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"8543_CR2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00520-018-4131-3","volume":"26","author":"M Aapro","year":"2018","unstructured":"Aapro M (2018) CINV: still troubling patients after all these years. Support Care Cancer 26(Suppl 1):5\u20139. https:\/\/doi.org\/10.1007\/s00520-018-4131-3","journal-title":"Support Care Cancer"},{"issue":"6","key":"8543_CR3","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/annonc\/mdx100","volume":"28","author":"G Dranitsaris","year":"2017","unstructured":"Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, Jordan K, Young A, Aapro M (2017) The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Ann Oncol 28(6):1260\u20131267. https:\/\/doi.org\/10.1093\/annonc\/mdx100","journal-title":"Ann Oncol"},{"issue":"1","key":"8543_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00520-018-4464-y","volume":"27","author":"Y Razvi","year":"2019","unstructured":"Razvi Y, Chan S, McFarlane T, McKenzie E, Zaki P, DeAngelis C, Pidduck W, Bushehri A, Chow E, Jerzak KJ (2019) ASCO, NCCN, MASCC\/ESMO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in adult patients. Support Care Cancer 27(1):87\u201395. https:\/\/doi.org\/10.1007\/s00520-018-4464-y","journal-title":"Support Care Cancer"},{"issue":"1","key":"8543_CR5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13012-018-0745-6","volume":"13","author":"MJ Armstrong","year":"2018","unstructured":"Armstrong MJ, Mullins CD, Gronseth GS, Gagliardi AR (2018) Impact of patient involvement on clinical practice guideline development: a parallel group study. Implement Sci 13(1):55. https:\/\/doi.org\/10.1186\/s13012-018-0745-6","journal-title":"Implement Sci"},{"issue":"1","key":"8543_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/hex.12997","volume":"23","author":"B Addario","year":"2020","unstructured":"Addario B, Geissler J, Horn MK, Krebs LU, Maskens D, Oliver K, Plate A, Schwartz E, Willmarth N (2020) Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials. Health Expect 23(1):41\u201351. https:\/\/doi.org\/10.1111\/hex.12997","journal-title":"Health Expect"},{"issue":"1","key":"8543_CR7","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/08998280.2017.11929552","volume":"30","author":"TE Paterick","year":"2017","unstructured":"Paterick TE, Patel N, Tajik AJ, Chandrasekaran K (2017) Improving health outcomes through patient education and partnerships with patients. Proc (Bayl Univ Med Cent) 30(1):112\u2013113. https:\/\/doi.org\/10.1080\/08998280.2017.11929552","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"7","key":"8543_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00520-023-07879-0","volume":"31","author":"A Molassiotis","year":"2023","unstructured":"Molassiotis A, Zhao IY, Crichton M, Olver I, Fleury M, Giusti R, Scotte F, Affronti ML (2023) Effects of food-based interventions in the management of chemoradiotherapy-induced nausea and vomiting: a systematic review. Support Care Cancer 31(7):413. https:\/\/doi.org\/10.1007\/s00520-023-07879-0","journal-title":"Support Care Cancer"},{"issue":"2","key":"8543_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jpainsymman.2006.10.018","volume":"34","author":"A Molassiotis","year":"2007","unstructured":"Molassiotis A, Coventry PA, Stricker CT, Clements C, Eaby B, Velders L, Rittenberg C, Gralla RJ (2007) Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage 34(2):148\u2013159. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.10.018","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"8543_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.6004\/jnccn.2012.0018","volume":"10","author":"JM Salsman","year":"2012","unstructured":"Salsman JM, Grunberg SM, Beaumont JL, Rogers M, Paul D, Clayman ML, Cella D (2012) Communicating about chemotherapy-induced nausea and vomiting: a comparison of patient and provider perspectives. J Natl Compr Canc Netw 10(2):149\u2013157. https:\/\/doi.org\/10.6004\/jnccn.2012.0018","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08543-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08543-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T12:05:38Z","timestamp":1718625938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08543-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,10]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["8543"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08543-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,10]]},"assertion":[{"value":"10 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This did not require an ethical approval or consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. No images or identifying information of human subjects were included in the publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Mary L. Affronti received funding from TeSera to conduct an investigator-initiated Phase II Study, is member of the MASCC Antiemetic study group and on the 2023 Antiemetic Guideline Consensus Committee (Chairs the Patient Antiemetic Guideline committee; Member of Integrative\/Nonpharmological Antiemetic Guideline committee) without financial compensation. Dr. Affronti is on the 2023 Society for Neuro-Oncology serving as Board Directors and receives no financial compensation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"335"}}